Eton Pharmaceuticals (ETON) Depreciation and Depletion (2018 - 2025)
Eton Pharmaceuticals (ETON) reported Depreciation and Depletion of $17000.0 for Q4 2025, down 55.26% on a YoY basis from $38000.0 in Q4 2024, and up 112.5% sequentially from $8000.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Depreciation and Depletion (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 8 years of Depreciation and Depletion data on file, last reported at $17000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation and Depletion fell 55.26% year-over-year to $17000.0; the trailing twelve-month figure through Dec 2025 stood at $41000.0 (down 46.05% YoY), and the FY2025 full-year result was $41000.0, down 18.0% from the prior year.
- Depreciation and Depletion rose to $17000.0 in Q4 2025, from $8000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $84000.0 in Q1 2021 to a low of $4000.0 in Q2 2025.
- A 5-year average of $19100.0 and a median of $13500.0 in 2022 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion slumped 75.0% in 2022 and soared 216.67% in 2024, its largest moves.
- Tracing ETON's Depreciation and Depletion over 5 years: stood at $23000.0 in 2021, then slumped by 43.48% to $13000.0 in 2022, then fell by 7.69% to $12000.0 in 2023, then soared by 216.67% to $38000.0 in 2024, then sank by 55.26% to $17000.0 in 2025.
- Business Quant data shows ETON's Depreciation and Depletion at $17000.0 in Q4 2025, $8000.0 in Q3 2025, and $4000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |